Open Access<p>Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma</p>
Author(s) -
Wei Li,
Qian Li,
Yiyi Yu,
Yan Wang,
Erbao Chen,
Lingli Chen,
Zhiming Wang,
Yuehong Cui,
Tianshu Liu
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s276969
Subject(s) - medicine , apatinib , chemotherapy , immunotherapy , nivolumab , cancer , oncology , gastroenterology , adenocarcinoma
Alpha-fetoprotein-producing gastric cancer (AFPGC) and hepatoid adenocarcinoma of stomach (HAS) are rare types of gastric cancer, with specific clinical manifestations and poor prognosis. The standardized treatment process of such cancers remains elusive. We aim to investigate the efficacy of immunotherapy combined with chemotherapy on patients with AFPGC or HAS.